Companies: 10,795·Total market cap: $144.5T

HeartSciences Inc.

HeartSciences Inc.

HSCSNASDAQHealthcare● Active

$1.84

$-0.10(-5.15%)

Market Cap$3987740

P/E Ratio—

52W High$6.47

52W Low$1.63

Avg Volume24K

Open$1.88

Beta1.97

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

HeartSciences Inc.（HSCS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HSCS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-4.94Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)8669.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding938,257Shares outstanding history

Next EarningsJul 23, 2026Est.Earnings history

探索 HeartSciences Inc. 数据

分析师预测$3 · Buy

股息不分红

营收$4350-76.61%

盈利EPS $-9.34+50.16%

财务快照

FY 2025Revenue$4350.00▼ 76.61% YoY

202320242025

FY 2025Net Income-$8.8M▼ 32.70% YoY

202320242025

FY 2025EPS$-9.34▲ +50.16% YoY

202320242025

TTM:Revenue: $8669.00Net Income: -$8.5MEPS: $-4.94View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$3.00Low

$1.84Current

$3.00Avg Target上涨空间 63.04%

$3.00High

合计: 3 · 买入占比: 100.0%

根据过去 3 个月内 3 位华尔街分析师，HSCS 共识评级为 Buy，12 个月平均目标价 $3.00 （较现价 $1.84 上涨空间 63.04%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

HeartSciences Inc.

$1.84-5.15%$4.0M #2

Autonomix Medical, Inc. Common Stock

$0.40-1.90%$2.1M #3

Brainstorm Cell Therapeutics Inc.

$0.80+6.87%$8.8M #4

Biomerica, Inc.

$2.07-2.36%$6.4M #5

$0.47-1.58%$433,577 #6

Impact BioMedical Inc.

$0.56-1.27%$7.0M

股票表现

1D-5.15%

1W-9.80%

1M-4.66%

3M-30.30%

YTD-40.45%

1Y-47.88%

5Y-98.92%

关于 HeartSciences Inc.

CEOAndrew Simpson

IPO DateJun 16, 2022

Employees15

CountryUS

Websiteheartsciences.com

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced …

Medical - Devices HealthcareNASDAQUS

关于股票概览与关键数据

HeartSciences Inc.（HSCS）是 Medical - Devices 行业的 Healthcare 类公司，于 Jun 16, 2022 在 NASDAQ 上市。截至最近交易日，HSCS 股价为 $1.84，市值约为 $4.0M。过去12个月累计回报 -47.88%，年初至今回报 -40.45%。

根据 3 位华尔街分析师，HeartSciences Inc. 股票共识评级为Buy，12个月平均目标价为 $3.00。2025 财年 HeartSciences Inc. 营收 $4350.00，净利润 -$8.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，HeartSciences Inc.（HSCS）股价为 $1.84，在 NASDAQ 上市，52周区间为 $1.63 – $6.47。

HSCS 最新股价HSCS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议